THE VALUE OF HETEROGENEITY FOR COST-EFFECTIVENESS SUBGROUP ANALYSIS: THEORETICAL FRAMEWORK AND APPLICATION

M. Espinoza; A. Manca; K. Claxton; M. J. Sculpher

doi:10.1016/j.jval.2011.08.052

THE VALUE OF HETEROGENEITY FOR COST-EFFECTIVENESS SUBGROUP ANALYSIS: THEORETICAL FRAMEWORK AND APPLICATION

M. Espinoza, A. Manca, K. Claxton, M. J. Sculpher

Research output: Contribution to journal › Meeting abstract › peer-review

Abstract

Decisions about the use of new medical technologies based on estimates of the average cost-effectiveness across a potentially heterogeneous population runs the risk of foregoing net health benefits(NHB) for sub-groups of the population. We propose a general framework within which to assess between-patient heterogeneity and its role in cost-effectiveness subgroup analysis(CESA), complementing this with a practical application.

Original language	English
Pages (from-to)	A241
Number of pages	1
Journal	Value in Health
Volume	14
Issue number	7
DOIs	https://doi.org/10.1016/j.jval.2011.08.052
Publication status	Published - Nov 2011

Access to Document

10.1016/j.jval.2011.08.052

Cite this

@article{f263aa45573f45c9885623dfcf66a225,

title = "THE VALUE OF HETEROGENEITY FOR COST-EFFECTIVENESS SUBGROUP ANALYSIS: THEORETICAL FRAMEWORK AND APPLICATION",

abstract = "Decisions about the use of new medical technologies based on estimates of the average cost-effectiveness across a potentially heterogeneous population runs the risk of foregoing net health benefits(NHB) for sub-groups of the population. We propose a general framework within which to assess between-patient heterogeneity and its role in cost-effectiveness subgroup analysis(CESA), complementing this with a practical application.",

author = "M. Espinoza and A. Manca and K. Claxton and Sculpher, {M. J.}",

year = "2011",

month = nov,

doi = "10.1016/j.jval.2011.08.052",

language = "English",

volume = "14",

pages = "A241",

journal = "Value in Health",

issn = "1098-3015",

publisher = "Elsevier",

number = "7",

}

TY - JOUR

T1 - THE VALUE OF HETEROGENEITY FOR COST-EFFECTIVENESS SUBGROUP ANALYSIS: THEORETICAL FRAMEWORK AND APPLICATION

AU - Espinoza, M.

AU - Manca, A.

AU - Claxton, K.

AU - Sculpher, M. J.

PY - 2011/11

Y1 - 2011/11

N2 - Decisions about the use of new medical technologies based on estimates of the average cost-effectiveness across a potentially heterogeneous population runs the risk of foregoing net health benefits(NHB) for sub-groups of the population. We propose a general framework within which to assess between-patient heterogeneity and its role in cost-effectiveness subgroup analysis(CESA), complementing this with a practical application.

AB - Decisions about the use of new medical technologies based on estimates of the average cost-effectiveness across a potentially heterogeneous population runs the risk of foregoing net health benefits(NHB) for sub-groups of the population. We propose a general framework within which to assess between-patient heterogeneity and its role in cost-effectiveness subgroup analysis(CESA), complementing this with a practical application.

U2 - 10.1016/j.jval.2011.08.052

DO - 10.1016/j.jval.2011.08.052

M3 - Meeting abstract

SN - 1098-3015

VL - 14

SP - A241

JO - Value in Health

JF - Value in Health

IS - 7

ER -